Tag Archives: KRYS

William Blair Keeps Their Buy Rating on Krystal Biotech (KRYS)

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Krystal Biotech (KRYS – Research Report). The company’s shares closed last Thursday at $71.77. According to TipRanks.com, Prasad is a 5-star analyst with an average

B.Riley Financial Remains a Buy on Krystal Biotech (KRYS)

B.Riley Financial analyst Justin Zelin reiterated a Buy rating on Krystal Biotech (KRYS – Research Report) today and set a price target of $100.00. The company’s shares closed last Tuesday at $41.68. According to TipRanks.com, Zelin is a 1-star analyst

Analysts Offer Insights on Healthcare Companies: and Krystal Biotech (NASDAQ: KRYS)

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Krystal Biotech (KRYS – Research Report) with bullish sentiments. Krystal Biotech (KRYS) In a report issued on September 17, Justin Zelin

Chardan Capital Keeps Their Buy Rating on Krystal Biotech (KRYS)

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on Krystal Biotech (KRYS – Research Report) today and set a price target of $115.00. The company’s shares closed last Tuesday at $47.63. According to TipRanks.com, Amusa is a 5-star analyst

Krystal Biotech (KRYS) Received its Third Buy in a Row

After William Blair and H.C. Wainwright gave Krystal Biotech (NASDAQ: KRYS) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy rating on Krystal Biotech today and set a

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (NASDAQ: KRYS) and BioCryst (NASDAQ: BCRX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Krystal Biotech (KRYS – Research Report) and BioCryst (BCRX – Research Report). Krystal Biotech (KRYS) In a report released today, Joseph Pantginis from